Free Trial

Coya Therapeutics (COYA) SEC Filings & 10K Form

Coya Therapeutics logo
$6.25 +0.22 (+3.65%)
(As of 01:16 PM ET)

Recent Coya Therapeutics SEC Filings

DateFilerForm TypeView
11/20/2024
4:15 PM
Coya Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
5:08 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
2:37 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/06/2024
7:06 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:02 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:02 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:27 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:42 AM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:42 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
8:08 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
8:10 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:04 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:13 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
5:10 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
4:31 PM
Coya Therapeutics (Filer)
Form 424B3
06/23/2024
11:15 PM
Coya Therapeutics (Filer)
Form EFFECT
06/05/2024
7:00 PM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:00 PM
Berman Howard (Reporting)
Coya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:00 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:20 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
4:21 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:40 PM
Coya Therapeutics (Filer)
Form ARS
03/28/2024
3:30 PM
Coya Therapeutics (Filer)
Form DEF 14A
03/28/2024
3:35 PM
Coya Therapeutics (Filer)
Form DEFA14A
03/19/2024
7:21 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:27 AM
Coya Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
7:00 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:46 PM
Coya Therapeutics (Subject)
GREENLIGHT CAPITAL INC (Filed by)
Form SC 13G/A
02/07/2024
5:55 PM
Coya Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G/A
02/02/2024
7:00 PM
Berman Howard (Reporting)
Coya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
7:00 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
7:00 PM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Garren Hideki (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:15 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2024
11:15 PM
Coya Therapeutics (Filer)
Form EFFECT
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

01/04/2024
3:46 PM
Coya Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/04/2024
3:05 PM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
7:00 AM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2023
8:46 AM
Coya Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/20/2023
7:35 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
6:30 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COYA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners